These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551 [TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors]. Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549 [No Abstract] [Full Text] [Related]
6. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039 [TBL] [Abstract][Full Text] [Related]
7. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002 [TBL] [Abstract][Full Text] [Related]
8. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483 [TBL] [Abstract][Full Text] [Related]
9. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy. Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951 [TBL] [Abstract][Full Text] [Related]
10. [Exploration on neoadjuvant chemoradiation in the treatment for locally advanced low rectal cancer]. Yu BM; Zhang M; Peng LH; Bian GW; Wu WQ; Chen LW; Fu J; Fei CS Zhonghua Wai Ke Za Zhi; 2009 Oct; 47(20):1540-3. PubMed ID: 20092741 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer]. Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. Mohiuddin M; Winter K; Mitchell E; Hanna N; Yuen A; Nichols C; Shane R; Hayostek C; Willett C; J Clin Oncol; 2006 Feb; 24(4):650-5. PubMed ID: 16446336 [TBL] [Abstract][Full Text] [Related]
14. [Study on the relationship between tumor regression grade and lymph node regression grade]. Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999 [TBL] [Abstract][Full Text] [Related]
17. Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity. Schaffer M; Thoma M; Wilkowski R; Schaffer P; Dühmke E Onkologie; 2002 Aug; 25(4):352-6. PubMed ID: 12232487 [TBL] [Abstract][Full Text] [Related]
18. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185 [TBL] [Abstract][Full Text] [Related]
19. [The safety and efficacy of radical surgery after modified total neoadjuvant therapy for locally advanced rectal cancer]. Zhang L; Yu L; Wu YL; Zhang QQ; Shen SH; Li DD; Fang H; Yang L; Zhang HZ Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):501-506. PubMed ID: 32575948 [No Abstract] [Full Text] [Related]
20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]